NL130099C - - Google Patents

Info

Publication number
NL130099C
NL130099C NL130099DA NL130099C NL 130099 C NL130099 C NL 130099C NL 130099D A NL130099D A NL 130099DA NL 130099 C NL130099 C NL 130099C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL130099C publication Critical patent/NL130099C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL130099D 1963-10-11 NL130099C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1254063A CH478139A (de) 1963-10-11 1963-10-11 Verfahren zur Herstellung neuer antibiotisch wirksamer Kondensationsprodukte von Rifamycin O
CH1004564A CH504457A (de) 1963-10-11 1964-07-31 Verfahren zur Herstellung neuer antibiotisch wirksamer Kondensationsprodukte von Rifamycin S
CH1179764 1964-09-10

Publications (1)

Publication Number Publication Date
NL130099C true NL130099C (fr)

Family

ID=27176360

Family Applications (2)

Application Number Title Priority Date Filing Date
NL130099D NL130099C (fr) 1963-10-11
NL6411794A NL6411794A (fr) 1963-10-11 1964-10-09

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6411794A NL6411794A (fr) 1963-10-11 1964-10-09

Country Status (14)

Country Link
US (1) US3338888A (fr)
AT (1) AT261805B (fr)
BE (1) BE654209A (fr)
BR (1) BR6463319D0 (fr)
CH (2) CH478139A (fr)
DE (1) DE1445634A1 (fr)
ES (1) ES304831A1 (fr)
FI (1) FI41029C (fr)
FR (4) FR4134M (fr)
GB (1) GB1081757A (fr)
IL (1) IL22215A (fr)
NL (2) NL6411794A (fr)
OA (1) OA01187A (fr)
SE (2) SE327501B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1165179A (en) * 1966-10-25 1969-09-24 Lepetit Spa Derivatives of Rifamycin SV
CH536851A (de) * 1966-10-25 1973-05-15 Ciba Geigy Ag Verfahren zur Herstellung neuer antibiotisch wirksamer Verbindungen der Rifamycinreihen
GB1159267A (en) * 1966-11-03 1969-07-23 Lepetit Spa Rifamycin Derivatives
IT1056271B (it) * 1975-05-20 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
US4690919A (en) * 1984-01-04 1987-09-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JPS63183587A (ja) * 1985-02-05 1988-07-28 Kanegafuchi Chem Ind Co Ltd ベンゾキサジノリフアマイシン誘導体
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
JP2544375B2 (ja) * 1986-07-14 1996-10-16 鐘淵化学工業株式会社 アルキル置換ベンゾキサジノリフアマイシン誘導体
DE68924722T2 (de) * 1988-03-18 1996-04-18 Kanegafuchi Chemical Ind Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
CA1304363C (fr) * 1988-11-01 1992-06-30 Takehiko Yamane Derive 3-hydroxybenzoxazinorifamycine, procede pour sa preparation et agent antibacterien en contenant
EP0787494B1 (fr) * 1995-09-01 2004-06-09 Kaneka Corporation Utilisation des derivates de rifamycine pour la manufacture d'un medicament contre les maladies causées par une infection par helicobacter pylori
CA2465846A1 (fr) * 2001-11-21 2003-06-05 Activbiotics, Inc. Agents therapeutiques cibles et leurs utilisations
WO2003051299A2 (fr) * 2001-12-13 2003-06-26 Activbiotics, Inc. Rifamycines au sulfhydryle et utilisations de ces dernieres
CN1894259A (zh) * 2003-08-22 2007-01-10 活跃生物工艺学公司 利福霉素类似物及其应用
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
EP1697382A4 (fr) * 2003-12-10 2008-11-05 Activbiotics Inc Analogues de la rifamycine et leurs utilisations
CA2550729A1 (fr) * 2003-12-23 2005-07-14 Activbiotics, Inc. Analogues de rifamycine et leurs utilisations

Also Published As

Publication number Publication date
BE654209A (fr) 1965-04-09
GB1081757A (en) 1967-08-31
US3338888A (en) 1967-08-29
SE327501B (fr) 1970-08-24
FI41029B (fr) 1969-04-30
IL22215A (en) 1968-06-20
FR4133M (fr) 1966-05-02
BR6463319D0 (pt) 1973-07-17
ES304831A1 (es) 1965-04-01
CH478139A (de) 1969-09-15
FR4152M (fr) 1966-05-09
FR4122M (fr) 1966-04-25
OA01187A (fr) 1969-01-25
SE342458B (fr) 1972-02-07
DE1445634A1 (de) 1968-12-05
CH504457A (de) 1971-03-15
FI41029C (fi) 1969-08-11
FR4134M (fr) 1966-05-02
AT261805B (de) 1968-05-10
NL6411794A (fr) 1965-04-12

Similar Documents

Publication Publication Date Title
AR142945A1 (fr)
FR4152M (fr)
AT260747B (fr)
FR3946M (fr)
BE627012A (fr)
BE643359A (fr)
BE627023A (fr)
BE627172A (fr)
BE645911A (fr)
BE645855A (fr)
BE645582A (fr)
BE645114A (fr)
BE645100A (fr)
BE644682A (fr)
BE643768A (fr)
BE643633A (fr)
BE641874A (fr)
BE642050A (fr)
BE627145A (fr)
BE627141A (fr)
BE627083A (fr)
BE627025A (fr)
BE627151A (fr)
BE626986A (fr)
BE626938A (fr)